Skip to main content
. Author manuscript; available in PMC: 2014 Apr 15.
Published in final edited form as: Eur Heart J. 2012 Jul 26;34(32):2566–2574. doi: 10.1093/eurheartj/ehs227

Table 1. Lipid profiles of apoE2-KI mice treated with FF or GFT505.

ApoE2-KI mice on a western-diet were treated by oral gavage with FF (200mpk) or GFT505 (10mpk) or vehicle for 14d (n=6 mice/group).

Vehicle FF GFT505

TG (mg/dL) 278 ± 76 156 ±62* 110 ±50*
Total cholesterol (mg/dL) 1006 ± 190 459 ± 201** 384 ± 142***
HDL-cholesterol (mg/dL) 26 ± 7 62 ± 11*** 71 ± 10***,#
non HDL-cholesterol (mg/dL) 980 ± 196 397 ± 203** 312 ± 142***

Values are expressed as means ± SEM. ANOVA;

*

P<.05;

**

P<.01;

***

P<.001 vs untreated mice;

#

P<.05 vs FF-treated mice.